| Literature DB >> 19465919 |
Koen J T Venken1, Joseph W Carlson, Karen L Schulze, Hongling Pan, Yuchun He, Rebecca Spokony, Kenneth H Wan, Maxim Koriabine, Pieter J de Jong, Kevin P White, Hugo J Bellen, Roger A Hoskins.
Abstract
We constructed Drosophila melanogaster bacterial artificial chromosome libraries with 21-kilobase and 83-kilobase inserts in the P[acman] system. We mapped clones representing 12-fold coverage and encompassing more than 95% of annotated genes onto the reference genome. These clones can be integrated into predetermined attP sites in the genome using UC31 integrase to rescue mutations. They can be modified through recombineering, for example, to incorporate protein tags and assess expression patterns.Entities:
Mesh:
Year: 2009 PMID: 19465919 PMCID: PMC2784134 DOI: 10.1038/nmeth.1331
Source DB: PubMed Journal: Nat Methods ISSN: 1548-7091 Impact factor: 28.547
Figure 1The P(acman) BAC Vector and Mapped Clones in the eve Region
(a) Map of attB-P(acman)-CmR-BW with partitioning functions (parA parB and parC), low-copy replication functions (repE and oriS), selectable marker (chloramphenicol acetyl transferase, Cm), conditionally inducible origin of replication (oriV) and dominant eye color marker white +. Genomic DNA was cloned into the BamHI site (Supplementary Fig. 2). (b) A 100-kb region surrounding the eve gene (yellow) on chromosome arm 2R. Mapped CHORI-321 and CHORI-322 clones are indicated below the FlyBase R5.9 gene annotation. CH322-103K22, selected for transformation (Supplementary Table 2) and protein tagging (Fig. 2), is indicated in red.
Characterization of CHORI-322 Clones
Genes contained in 38 CHORI-322 clones are indicated. For each clone, the deduced genomic insert length in bp (insert), attP VK docking site used (VK#), number of fertile G0 crosses (G0), number of vials resulting in at least one transgenic animal (Tr) and integration efficiency (%) are indicated. Note that only the gene of interest is shown; most clones contain more than one gene.
| 19,321 | 33 | 84 | 2 | 2.4% | ||
| 19,317 | 37 | 65 | 5 | 7.7% | ||
| 20,091 | 37 | 51 | 1 | 2.0% | ||
| 18,452 | 37 | 59 | 4 | 6.8% | ||
| 20,115 | 33 | 103 | 4 | 3.9% | ||
| 19,815 | 37 | 24 | 3 | 12.5% | ||
| 17,647 | 33 | 57 | 8 | 14.0% | ||
| 20,882 | 37 | 32 | 2 | 6.3% | ||
| 23,790 | 16 | 44 | 5 | 11.4% | ||
| 22 | 11 | 2 | 18.2% | |||
| 37 | 115 | 0 | 0.0% | |||
| 22,027 | 33 | 73 | 1 | 1.4% | ||
| 20,342 | 33 | 69 | 2 | 2.9% | ||
| 19,373 | 33 | 115 | 2 | 1.7% | ||
| 20,365 | 37 | 25 | 1 | 4.0% | ||
| 21,222 | 33 | 61 | 1 | 1.6% | ||
| 20,644 | 37 | 70 | 1 | 1.4% | ||
| 20,846 | 37 | 51 | 1 | 2.0% | ||
| 22,025 | 33 | 56 | 3 | 5.4% | ||
| 22,752 | 37 | 38 | 2 | 5.3% | ||
| 21,662 | 33 | 63 | 1 | 1.6% | ||
| 22,196 | 37 | 104 | 4 | 3.8% | ||
| 24,376 | 37 | 87 | 2 | 2.3% | ||
| 21,688 | 37 | 45 | 3 | 6.7% | ||
| 21,536 | 37 | 48 | 1 | 2.1% | ||
| 22,329 | 33 | 109 | 1 | 0.9% | ||
| 21,251 | 37 | 76 | 4 | 5.3% | ||
| 22,049 | 33 | 71 | 1 | 1.4% | ||
| 24,728 | 33 | 43 | 2 | 4.7% | ||
| 23,954 | 37 | 28 | 1 | 3.6% | ||
| 20,416 | 33 | 59 | 4 | 6.8% | ||
| 21,979 | 37 | 58 | 2 | 3.4% | ||
| 19,175 | 37 | 49 | 9 | 18.4% | ||
| 23,226 | 37 | 39 | 2 | 5.1% | ||
| 20,074 | 33 | 65 | 8 | 12.3% | ||
| 20,978 | 33 | 57 | 3 | 5.3% | ||
| 18,311 | 33 | 36 | 1 | 2.8% | ||
| 18,384 | 37 | 45 | 1 | 2.2% | ||
| 19,299 | 37 | 53 | 3 | 5.7% | ||
| 22,791 | 13 | 21 | 0 | 0.0% | ||
| 31 | 35 | 5 | 14.3% | |||
| 33 | 78 | 0 | 0.0% |
Characterization of CHORI-321 Clones
Genes contained in 24 CHORI-321 clones are indicated Colum headings are identical to those in Table 1.
| 77,150 | 33 | 62 | 2 | 3.2% | ||
| 83,080 | 33 | 65 | 1 | 1.5% | ||
| 91,022 | 33 | 81 | 1 | 1.2% | ||
| 86,898 | 33 | 41 | 1 | 2.4% | ||
| 87,314 | 33 | 99 | 2 | 2.0% | ||
| 97,072 | 33 | 56 | 1 | 1.8% | ||
| 92,406 | 37 | 51 | 0 | 0.0% | ||
| 77,006 | 33 | 76 | 0 | 0.0% | ||
| 101,201 | 37 | 61 | 0 | 0.0% | ||
| 104,925 | 33 | 63 | 1 | 1.6% | ||
| 85,274 | 33 | 107 | 0 | 0.0% | ||
| 86,475 | 33 | 62 | 1 | 1.6% | ||
| 92,518 | 37 | 46 | 0 | 0.0% | ||
| 92,084 | 33 | 66 | 6 | 9.1% | ||
| 92,368 | 33 | 60 | 4 | 6.7% | ||
| 78,102 | 33 | 64 | 2 | 3.1% | ||
| 98,254 | 33 | 68 | 0 | 0.0% | ||
| 53,704 | 33 | 63 | 0 | 0.0% | ||
| 102,491 | 33 | 79 | 0 | 0.0% | ||
| 88,712 | 33 | 76 | 2 | 2.6% | ||
| 70,514 | 33 | 53 | 0 | 0.0% | ||
| 82,244 | 33 | 59 | 0 | 0.0% | ||
| 76,842 | 33 | 69 | 8 | 11.6% | ||
| 80,238 | 33 | 62 | 0 | 0.0% |
Figure 2Expression of EGFP Fusion Proteins in Transgenic Embryos
Fusion proteins were detected using an anti-GFP antibody and peroxidase staining. (a-d) Expression of an even skipped fusion construct recapitulates the native pattern of Eve expression. (a) embryonic stage 5, (b) embryonic stage 9, (c) embryonic stage 11, (d) embryonic stage 15. (e) Dichaete, embryonic stage 5. (f) caudal, embryonic stage 9. (g) Deformed, embryonic stage 11. (h) tailless, embryonic stage 5. (i) sloppy paired 2, embryonic stage 17. (j) extradenticle, embryonic stage 15. (k) engrailed, embryonic stage 9. (l) hairy, embryonic stage 6. Scale bar (a) indicates 50 µm.